Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis
Sponsor: Reistone Biopharma Company Limited
Summary
This study is ongoing to explore the efficacy and safety of different strengths of RSS0393 ointment in adults with atopic dermatitis
Official title: A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study Evaluating the Efficacy and Safety of RSS0393 Ointment in Adults With Mild to Moderate Atopic Dermatitis
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
168
Start Date
2025-09-25
Completion Date
2026-05
Last Updated
2026-01-29
Healthy Volunteers
No
Conditions
Interventions
RSS0393 ointment
RSS0393 ointment 0.05%
RSS0393 ointment
RSS0393 ointment 0.01%
RSS0393 ointment
RSS0393 ointment 0.03%
RSS0393 ointment
RSS0393 ointment placebo
Locations (1)
Dermatology Hospital of Southern Medical University
Guangzhou, Guangdong, China